|
Healthcare professional reported that patient experienced paradoxical hyperplasia to the arm (upper and lower) after treatment on (b)(6) 2021, coolsculpting elite system treatment on (b)(6) 2026 using flat 165 applicator, and coolsculpting system on (b)(6) 2021 using the coolfit applicator.
|
|
Paradoxical adipose hyperplasia (ph) is a known potential adverse event addressed in the product labeling.According to the coolsculpting user manual, under rare adverse events, ph is characterized by a visibly enlarged tissue volume within the treatment area, which may develop two to five months after treatment.Surgical intervention may be required.Ph is not related to any coolsculpting device failure mode but it is included in the risk management files of the device because it is a risk that is inherent to the use cryolipolysis for localized fat reduction.A supplemental report will be submitted if and when additional information is obtained.Recall:
zeltiq initiated a voluntary discontinuation and recall of parallel plate applicators for the coolsculpting system due to the observance of an increased rate of paradoxical hyperplasia (ph) associated with these applicators during a recent analysis of data from the 2019-2021 timeframe.These applicators are sold under the brand names coolcore, coolcurve, coolcurve+, coolmax and coolfit.Concomitant devices:
coolsculpting system
serial number: unknown
catalog number: unknown
lot number: ni
udi: unknown
manufacturing date: unknown
coolsculpting elite system
serial number: (b)(6)
catalog number: cs-s3-002-d-00
lot number: ni
udi: (b)(4)
manufacturing date: 07/february/2023
coolsculpting elite system
serial number: (b)(6)
catalog number: cs-s3-002-d-00
lot number: ni
udi: (b)(4)
manufacturing date: 07/february/2023.
|